Respiratory Illness News and Research RSS Feed - Respiratory Illness News and Research

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection. [More]
Recommendation by physician could halve racial disparity in who gets flu shot

Recommendation by physician could halve racial disparity in who gets flu shot

Doctors should make a point of offering a flu vaccine to their patients. A simple reminder could considerably reduce the number of racial and ethnic minorities who currently do not vaccinate themselves against this common contagious respiratory illness. [More]
Expert panel issues key suggestions related to unconventional natural gas drilling operations

Expert panel issues key suggestions related to unconventional natural gas drilling operations

Groundwater and air quality testing before, during, and after natural gas drilling - which includes hydraulic fracturing -- should be key components of efforts to ensure the safety of communities near these sites, according to an expert panel convened to weigh in on public health research needs associated with unconventional natural gas drilling operations (UNGDO). [More]
Saudi Arabian researchers detect genetic fragments of MERS-CoV in the air of camel barn

Saudi Arabian researchers detect genetic fragments of MERS-CoV in the air of camel barn

Saudi Arabian researchers have detected genetic fragments of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in the air of a barn holding a camel infected with the virus. The work, published this week in mBio-, the online open-access journal of the American Society for Microbiology, indicates that further studies are needed to see if the disease can be transmitted through the air. [More]
Current recommendations advise prompt antiviral treatment for high-risk patients with influenza

Current recommendations advise prompt antiviral treatment for high-risk patients with influenza

Patients likely to benefit the most from antiviral therapy for influenza were prescribed these drugs infrequently during the 2012-2013 influenza season, while antibiotics may have been overprescribed. [More]
GSK begins shipment of flu vaccines to U.S. for the upcoming 2014-15 season

GSK begins shipment of flu vaccines to U.S. for the upcoming 2014-15 season

GSK announced today it has begun shipping FLUARIX QUADRIVALENT (Influenza Vaccine) doses to U.S. healthcare providers. This is the first shipment of GSK’s U.S. flu vaccine supply for the flu season, following licensing and lot-release approval from the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research. [More]
Experts release position statement on electronic cigarettes

Experts release position statement on electronic cigarettes

Experts from the world's leading lung organizations have released a position statement on electronic cigarettes, focusing on their potential adverse effects on human health and calling on governments to ban or restrict their use until their health impacts are better known. [More]
Legionnaires may be able to grow in windshield washer fluid

Legionnaires may be able to grow in windshield washer fluid

A form of bacteria responsible for respiratory illness, including the deadly pneumonia known as Legionnaire's disease, may be able to grow in windshield washer fluid and was isolated from nearly 75% of school buses tested in one district in Arizona, according to research presented today at the annual meeting of the American Society for Microbiology. [More]
State highlights: 'Balance billing' protection in N.Y.; L.A. nursing home complaint backlog

State highlights: 'Balance billing' protection in N.Y.; L.A. nursing home complaint backlog

Hospital patients in New York are the latest in the nation to gain legal protection against unexpected bills from doctors who won't accept their insurance. [More]
First Edition: April 7, 2014

First Edition: April 7, 2014

Today's headlines include stories about the next round of health law challenges the Obama administration faces as well as the new Medicare Advantage rates scheduled to be announced today. [More]
Researchers identify polio-like syndrome in cluster of children from California

Researchers identify polio-like syndrome in cluster of children from California

Researchers have identified a polio-like syndrome in a cluster of children from California over a one-year period, according to a case report released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014. [More]
Coronavirus responsible for MERS is prevalent in camels throughout Saudi Arabia

Coronavirus responsible for MERS is prevalent in camels throughout Saudi Arabia

The coronavirus responsible for Middle East Respiratory Syndrome (MERS) is prevalent in camels throughout Saudi Arabia and has been around for at least 20 years, according to a study to be published on February 25 in mBio-, the online open-access journal of the American Society for Microbiology. [More]
Bubble CPAP device increases survival rate of newborns with severe respiratory illness

Bubble CPAP device increases survival rate of newborns with severe respiratory illness

The first clinical study of a low-cost neonatal breathing system created by Rice University bioengineering students demonstrated that the device increased the survival rate of newborns with severe respiratory illness from 44 percent to 71 percent. [More]
AIT initiates Phase II clinical trial of NOxCureCF for patients with cystic fibrosis

AIT initiates Phase II clinical trial of NOxCureCF for patients with cystic fibrosis

Advanced Inhalation Therapies, an Israeli drug development company, announced today that it has begun enrollment in Israel for a multicenter, open label, Phase II clinical trial of NOxCureCF, a respiratory treatment for patients with cystic fibrosis. [More]
GSK's FluLaval Quadrivalent vaccine effective in reducing flu cases in children

GSK's FluLaval Quadrivalent vaccine effective in reducing flu cases in children

GlaxoSmithKline plc announced today that a peer-reviewed study issued online by the New England Journal of Medicine has reported that GSK's FluLaval® Quadrivalent reduced flu cases among children ages 3-8 by 55.4% overall and lowered the risk of developing moderate-to-serious flu illness by 73.1%. [More]
ATS Labs offers testing of antimicrobial products for efficacy against H7N9 virus

ATS Labs offers testing of antimicrobial products for efficacy against H7N9 virus

ATS Labs announced today that they are pleased to offer testing of antimicrobial products for efficacy against avian influenza A (H7N9) virus. Avian influenza A (H7N9) virus, called H7N9 for short, has infected humans in China causing severe respiratory illness. [More]
DNA vaccine demonstrates potential to prevent and treat deadly MERS coronavirus

DNA vaccine demonstrates potential to prevent and treat deadly MERS coronavirus

Inovio Pharmaceuticals, Inc. announced today that preclinical testing of a DNA synthetic vaccine for the virulent Middle East Respiratory Syndrome coronavirus (MERS) induced robust and durable immune responses, demonstrating the potential for a SynCon DNA vaccine to prevent and treat this deadly virus. [More]
Diagnosing influenza with rapid tests leads to more efficient care

Diagnosing influenza with rapid tests leads to more efficient care

When patients in the emergency department (ED) are diagnosed with influenza by means of a rapid test, they get fewer unnecessary antibiotics, are prescribed antiviral medications more frequently, and have fewer additional lab tests compared to patients diagnosed with influenza without testing, according to a new study. Published online in the Journal of the Pediatrics Infectious Diseases Society, the findings suggest that diagnosing influenza with a rapid diagnostic test leads to more appropriate, specific, and efficient care. [More]
FMCNA encourages dialysis patients to get vaccinated against flu

FMCNA encourages dialysis patients to get vaccinated against flu

With early cases of seasonal flu already being reported in the U.S., Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is strongly encouraging dialysis patients to get flu shots to protect themselves against this common infectious disease. [More]
Ten health care innovations could save lives of mothers and children

Ten health care innovations could save lives of mothers and children

Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015. [More]